These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 15160341)
1. Prognostic significance of erythropoietin expression in human endometrial carcinoma. Acs G; Xu X; Chu C; Acs P; Verma A Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341 [TBL] [Abstract][Full Text] [Related]
2. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression. Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338 [TBL] [Abstract][Full Text] [Related]
4. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI; Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma. Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. Giatromanolaki A; Fiska A; Pitsiava D; Kartalis G; Koukourakis MI; Sivridis E In Vivo; 2009; 23(5):699-703. PubMed ID: 19779103 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237 [TBL] [Abstract][Full Text] [Related]
9. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells. Acs G; Chen M; Xu X; Acs P; Verma A; Koch CJ Cancer Lett; 2004 Oct; 214(2):243-51. PubMed ID: 15363551 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G; Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer. Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma. Li HG; Li JS; Chen WL; Wang L; Wu DH; Lin ZY Br J Oral Maxillofac Surg; 2009 Sep; 47(6):470-5. PubMed ID: 19559511 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas. Segawa T; Sasagawa T; Saijoh K; Inoue M Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas. Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214 [TBL] [Abstract][Full Text] [Related]
18. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis. Giatromanolaki A; Koukourakis MI; Gatter KC; Harris AL; Sivridis E J Clin Pathol; 2008 Feb; 61(2):217-20. PubMed ID: 17513511 [TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]